It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Radiation therapy remains one of the most important tools for treating cancer, but experts say patients receiving radiation near the chest should also be aware of potential long-term heart risks.

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT screenings for those eligible – the disease can be completely curable.

Adelaide newsreader Will McDonald has managed his aggressive stage 4 prostate cancer for six years now, although he knows the intensive drug regime he is on, while doing the trick for now, won’t last ...

A Bay Area family has found purpose in their journey with cancer and a calling to help others. The backstory. Vincent DiTinno’s parents say he started having abnor ...

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...

At the 2026 Miami Breast Cancer Conference, Kevin Kalinsky, MD, MS, participated in a molecular tumor board session that brought together a multidisciplinary panel including medic ...

Intent-to-treat median PFS was 10.2 months with nivolumab/ipilimumab versus 6.3 months with added SBRT, with 12-month PFS 47.8% versus 34.9% (HR 1.20; P=.56). Per-protocol analysis after four ...

Alpha Tau Medical Ltd ( (DRTS) ) has shared an update.